Chapter 1. MYCOPLASMA TESTING MARKET – Scope & Methodology

1.1. Market Segmentation

1.2. Assumptions

1.3. Research Methodology

1.4. Primary Sources

1.5. Secondary Sources

Chapter 2. MYCOPLASMA TESTING MARKET – Executive Summary

2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)

2.2. Key Trends & Insights  

2.3. COVID-19 Impact Analysis

      2.3.1. Impact during 2023 – 2030

      2.3.2. Impact on Supply – Demand

Chapter 3. MYCOPLASMA TESTING MARKET – Competition Scenario

3.1. Market Share Analysis

3.2. Product Benchmarking

3.3. Competitive Strategy & Development Scenario

3.4. Competitive Pricing Analysis

3.5. Supplier - Distributor Analysis

Chapter 4. MYCOPLASMA TESTING MARK ET - Entry Scenario

4.1. Case Studies – Start-up/Thriving Companies

4.2. Regulatory Scenario - By Region

4.3 Customer Analysis

4.4. Porter's Five Force Model

       4.4.1. Bargaining Power of Suppliers

       4.4.2. Bargaining Powers of Customers

       4.4.3. Threat of New Entrants

       4.4.4. Rivalry among Existing Players

       4.4.5. Threat of Substitutes

Chapter 5. MYCOPLASMA TESTING MARKET - Landscape

5.1. Value Chain Analysis – Key Stakeholders Impact Analysis

5.2. Market Drivers

5.3. Market Restraints/Challenges

5.4. Market Opportunities

Chapter 6. MYCOPLASMA TESTING MARKET – By Product

6.1 Instruments

6.2. Kits & Reagents

6.2.1. PCR Assays

6.2.2. Nucleic Acid Detection Kits

6.2.3. Stains

6.2.4. Elimination Kits

6.2.5. Standards & Controls

6.2.6. Others

6.3. Services

Chapter 7. MYCOPLASMA TESTING MARKET – By Technology

7.1 PCR

7.2. ELISA

7.3. Direct Assay

7.4. Indirect Assay

7.5. Microbial Culture Techniques

7.6. Enzymatic Methods

Chapter 8. MYCOPLASMA TESTING MARKET – By Application

8.1 Cell Line Testing

8.2. Virus Testing

8.3. End of Production Cells Testing

8.4. Others

Chapter 9. MYCOPLASMA TESTING MARKET –By End-Use

9.1 Academic Research Institutes

9.2. Cell Banks

9.3. Contract Research Organizations

9.4. Pharmaceutical & Biotechnology Companies

9.5. Others

Chapter 10. MYCOPLASMA TESTING MARKET – By Region

10.1. North America

10.2. Europe

10.3.The Asia Pacific

10.4.Latin America

10.5. Middle-East and Africa

Chapter 11. MYCOPLASMA TESTING MARKET– Company Profiles – (Overview, Product Portfolio, Financials, Developments)

11.1. Company 1

11.2. Company 2

11.3. Company 3

11.4. Company 4

11.5. Company 5

11.6. Company 6

11.7. Company 7

11.8. Company 8

11.9. Company 9

11.10. Company  10